Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective Immune Tolerance: A Unifying Mechanism Linking Heavy Malaria Exposure, Waning Vaccine Antibodies, and Burkitt Lymphoma.

The Journal of infectious diseases·2026
Same author

A kinetics-based model of haematopoiesis reveals extrinsic regulation of skewed lineage output from stem cells.

Nature cell biology·2026
Same author

Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblasts.

Science translational medicine·2026
Same author

The spectrum of immunoglobulin heavy chain enhancer hijacking in chronic lymphocytic leukemia.

Leukemia·2026
Same author

Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor.

Nature communications·2026
Same author

Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma.

Nature cancer·2026

Related Experiment Video

Updated: May 17, 2025

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

9.8K

Subtyping Burkitt Lymphoma by DNA Methylation.

Selina Glaser1, Rabea Wagener1,2, Helene Kretzmer3,4

  • 1Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.

Genes, Chromosomes & Cancer
|April 7, 2025
PubMed
Summary
This summary is machine-generated.

Epstein-Barr virus (EBV) status, not traditional variants, defines Burkitt lymphoma (BL) subgroups based on DNA methylation. EBV-positive BL shows distinct epigenetic patterns and gene regulation compared to EBV-negative BL.

Keywords:
AfricaBurkitt lymphomaDNA methylationEpstein–Barr virusimmunodeficiency

More Related Videos

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
13:47

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Published on: February 24, 2015

25.4K
Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

8.6K

Related Experiment Videos

Last Updated: May 17, 2025

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

9.8K
Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
13:47

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Published on: February 24, 2015

25.4K
Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

8.6K

Area of Science:

  • Oncology
  • Epigenetics
  • Virology

Background:

  • Burkitt lymphoma (BL) is an aggressive B-cell malignancy with historically defined variants.
  • Epstein-Barr virus (EBV) positivity frequency differs across BL variants.
  • Understanding BL heterogeneity is crucial for targeted therapies.

Purpose of the Study:

  • To identify subgroups of Burkitt lymphoma based on DNA methylation patterns.
  • To investigate the influence of Epstein-Barr virus (EBV) status on DNA methylation profiles.
  • To correlate methylation subgroups with clinical and molecular features.

Main Methods:

  • DNA methylation profiling of 96 BL cases, 17 BL cell lines, and 6 EBV-transformed lymphoblastoid cell lines using Illumina BeadChip arrays.
  • Clustering analysis to identify methylation-based subgroups.
  • Analysis of CpG methylation patterns, epigenetic age, and gene regulatory elements.

Main Results:

  • Four distinct DNA methylation subgroups were identified: two predominantly EBV-positive (BL-mC1, BL-mC2) and two predominantly EBV-negative (BL-mC3, BL-mC4).
  • EBV-positive subgroups exhibited increased DNA methylation and epigenetic age.
  • Hypermethylated CpGs in EBV-positive BL were associated with Polycomb Repressive Complex 2 marks, while hypomethylated CpGs in EBV-negative BL linked to B-cell receptor signaling.
  • EBV-associated hypermethylation impacted regulatory regions of key BL-mutated genes (e.g., CCND3, TP53) and superenhancers.

Conclusions:

  • Epstein-Barr virus (EBV) status is the primary driver of DNA methylation-based subgrouping in Burkitt lymphoma.
  • DNA methylation patterns reveal distinct epigenetic landscapes associated with EBV positivity.
  • These findings suggest EBV-driven hypermethylation may influence oncogenic pathways and compensate for lower mutational burden in EBV-positive BL.